PEDIATRICS · 2009 · 38 citations · 23 references
MedicineChild HealthPediatricsInfant HealthNeonatologyPulmonologyBronchopulmonary DysplasiaLung DevelopmentNeonatal Respiratory DisordersNeonatal VentilationRespiratory DiseaseRespiratory Distress In NewbornsChronic Lung Disease RiskGestational Age MeasurementNeonatal Chronic Lung DiseaseNeonatal Mechanical VentilationRespiratory Outcomes In PrematuritySurfactant UseVascular Endothelial Growth FactorVascular Endothelial Growth Factor Receptors
OBJECTIVE: We tested the hypothesis that soluble vascular endothelial growth factor receptors are involved in the development of bronchopulmonary dysplasia/chronic lung disease. PATIENTS AND METHODS: Neonates with a birth weight of < or =1500 g and/or < or =30 weeks' gestation, with respiratory failure, requiring O(2) and mechanical ventilation within 24 hours, were eligible. Tracheal aspirate fluid samples were collected from 65 neonates before surfactant and/or assisted mechanical ventilation (baseline), at 3 and 7 days after birth, and weekly thereafter until extubation. Samples were analyzed for total vascular endothelial growth factor, soluble vascular endothelial growth factor receptor 1 and 2 levels and compared in infants with bronchopulmonary dysplasia/chronic lung disease (n = 31) versus those with no bronchopulmonary dysplasia/chronic lung disease (n = 34). RESULTS: Mean gestational age and birth weight were lower in infants with bronchopulmonary dysplasia/chronic lung disease. At baseline, vascular endothelial growth factor levels in the tracheal aspirate fluid were significantly lower, whereas soluble vascular endothelial growth factor receptor 1 levels were higher in the bronchopulmonary dysplasia/chronic lung disease infants compared with infants with no bronchopulmonary dysplasia/chronic lung disease. Vascular endothelial growth factor levels progressively increased from baseline to 4 weeks in all of the infants developing bronchopulmonary dysplasia/chronic lung disease. Conversely, soluble vascular endothelial growth factor receptor 1 declined in both groups from baseline to 5 weeks of age. Similarly, soluble vascular endothelial growth factor receptor 2 declined from baseline to 5 weeks in the control infants, but there were significant increases at 3 and 4 weeks in infants developing bronchopulmonary dysplasia/chronic lung disease. CONCLUSIONS: We speculate that low vascular endothelial growth factor levels in tracheal aspirate fluid, concurrent with elevated soluble vascular endothelial growth factor receptor 1 levels on the first day of life, are biological markers for the development of bronchopulmonary dysplasia/chronic lung disease in very low birth weight infants requiring O(2) and assisted mechanical ventilation.
23
Alan H. Jobe, Eduardo Bancalari · American Journal of Respiratory and Critical Care Medicine · 2001 · 4.8K citations
Medicine, Child Health, Pediatrics +15
Sharon E. Maynard, Jiang-Yong Min, Jaime R. Merchan et al. · Journal of Clinical Investigation · 2003 · 4K citations · Full text
New Ballard Score, expanded to include extremely premature infants
J. Ballard, Jane Khoury, Kathy E. Wedig et al. · The Journal of Pediatrics · 1991 · 2K citations